Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Pitney Bowes
PBI
$2.37B
| $307K | ﹤0.01% |
+86,664
| New | +$300K |
|
4802
Sight Sciences
SGHT
$463M
| $306K | ﹤0.01% |
36,952
-299,960
| -89% | -$2.7M |
|
4803
CALL
Wayfair
W
$14.4B
| $306K | ﹤0.01% |
4,700
-291,400
| -98% | -$12.3M |
|
4804
Marcus & Millichap
MMI
$1.2B
| $305K | ﹤0.01% |
+9,692
| New | +$300K |
|
4805
CALL
Intercontinental Exchange
ICE
$90.5B
| $305K | ﹤0.01% |
2,700
| – | – |
|
4806
ProShares UltraPro Dow 30
UDOW
$873M
| $305K | ﹤0.01% |
+10,232
| New | +$290K |
|
|
VBNK
4807
VersaBank
VBNK
$664M
| $305K | ﹤0.01% |
40,727
+18,426
| +83% | +$133K |
|
|
NOVA
4808
DELISTED
Sunnova Energy
NOVA
| $305K | ﹤0.01% |
16,631
-4,245
| -20% | -$72K |
|
4809
PUT
Pliant Therapeutics
PLRX
$71.2M
| $304K | ﹤0.01% |
+16,800
| New | +$398K |
|
4810
CALL
Chewy
CHWY
$9.33B
| $304K | ﹤0.01% |
+7,700
| New | +$268K |
|
4811
iShares Global REIT ETF
REET
$5.03B
| $302K | ﹤0.01% |
+13,147
| New | +$300K |
|
4812
LifeVantage
LFVN
$81.4M
| $302K | ﹤0.01% |
69,400
+2,138
| +3% | +$8.83K |
|
4813
PUT
Axsome Therapeutics
AXSM
$10.8B
| $302K | ﹤0.01% |
+4,200
| New | +$310K |
|
4814
PUT
TriplePoint Venture Growth BDC
TPVG
$217M
| $302K | ﹤0.01% |
+25,600
| New | +$289K |
|
|
CANO
4815
DELISTED
Cano Health, Inc.
CANO
| $301K | ﹤0.01% |
2,168
-27,918
| -93% | -$3.58M |
|
4816
BigBear.ai
BBAI
$1.53B
| $300K | ﹤0.01% |
127,583
+69,747
| +121% | +$177K |
|
4817
Lesaka Technologies
LSAK
$391M
| $300K | ﹤0.01% |
+78,633
| New | +$302K |
|
|
NGM
4818
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $299K | ﹤0.01% |
115,604
-547,362
| -83% | -$1.95M |
|
4819
Schwab US Broad Market ETF
SCHB
$44.9B
| $299K | ﹤0.01% |
+17,361
| New | +$283K |
|
4820
iShares MSCI Israel ETF
EIS
$914M
| $299K | ﹤0.01% |
+5,582
| New | +$302K |
|
4821
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $299K | ﹤0.01% |
+7,304
| New | +$300K |
|
|
ANSS
4822
CALL
DELISTED
Ansys
ANSS
| $297K | ﹤0.01% |
+900
| New | +$285K |
|
4823
Genmab
GMAB
$21B
| $296K | ﹤0.01% |
7,781
-298,641
| -97% | -$11.9M |
|
4824
CALL
AC Immune
ACIU
$269M
| $296K | ﹤0.01% |
+100,000
| New | +$218K |
|
4825
Karooooo
KARO
$2.07B
| $295K | ﹤0.01% |
12,657
+2,156
| +21% | +$48.8K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.